Search Results - "Ouvrard‐Pascaud, Antoine"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Aldosterone promotes cardiac endothelial cell proliferation in vivo by Gravez, Basile, Tarjus, Antoine, Pelloux, Véronique, Ouvrard-Pascaud, Antoine, Delcayre, Claude, Samuel, Janelise, Clément, Karine, Farman, Nicolette, Jaisser, Fréderic, Messaoudi, Smail

    Published in Journal of the American Heart Association (06-01-2015)
    “…Experimentally, aldosterone in association with NaCl induces cardiac fibrosis, oxidative stress, and inflammation through mineralocorticoid receptor…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness by Galmiche, Guillaume, Pizard, Anne, Gueret, Alexandre, El Moghrabi, Soumaya, Ouvrard-Pascaud, Antoine, Berger, Stefan, Challande, Pascal, Jaffe, Iris Z., Labat, Carlos, Lacolley, Patrick, Jaisser, Frédéric

    Published in Hypertension (Dallas, Tex. 1979) (01-03-2014)
    “…Arterial stiffness is recognized as a risk factor for many cardiovascular diseases. Aldosterone via its binding to and activation of the mineralocorticoid…”
    Get full text
    Journal Article
  9. 9

    Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition by Ibarrola, Jaime, Matilla, Lara, Martínez-Martínez, Ernesto, Gueret, Alexandre, Fernández-Celis, Amaya, Henry, Jean-Paul, Nicol, Lionel, Jaisser, Frederic, Mulder, Paul, Ouvrard-Pascaud, Antoine, López-Andrés, Natalia

    Published in Scientific reports (03-07-2019)
    “…Although optimal therapy for myocardial infarction includes reperfusion to restore blood flow to the ischemic region, ischemia/reperfusion (IR) also initiates…”
    Get full text
    Journal Article
  10. 10

    Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice by Bonnard, Benjamin, Pieronne-Deperrois, Marie, Djerada, Zoubir, Elmoghrabi, Soumaya, Kolkhof, Peter, Ouvrard-Pascaud, Antoine, Mulder, Paul, Jaisser, Frédéric, Messaoudi, Smail

    “…Managing the cardiovascular complications of renal failure is a major therapeutic challenge in clinical practice. Mineralocorticoid Receptor (MR) blockade is a…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Conditional Transgenic Mice for Studying the Role of the Glucocorticoid Receptor in the Renal Collecting Duct by Nguyen Dinh Cat, Aurélie, Ouvrard-Pascaud, Antoine, Tronche, François, Clemessy, Maud, Gonzalez-Nunez, Daniel, Farman, Nicolette, Jaisser, Frederic

    Published in Endocrinology (Philadelphia) (01-05-2009)
    “…The mineralocorticoid receptor (MR) is a major regulator of renal sodium reabsorption and body fluid homeostasis. However, little is known about glucocorticoid…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone by Filardi, Tiziana, Feraco, Alessandra, Ouvrard-Pascaud, Antoine, Rizzo, Manfredi, Caprio, Massimiliano

    Published in Journal of diabetes and its complications (01-05-2024)
    “…•Diabetic kidney disease (DKD) develops in nearly 40% of patients with diabetes, and is a leading cause of end-stage renal disease…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Finerenone improves HFpEF in obese female mice and slows down its acceleration after a postmenopausal transition by Monmirel, Manon, Frimat, Coralie, Charrabi, Azzouz, Fauvel, Charles, Valet, Manon, Noel, Tony, Fernandes-Rosa, Fabio, Mulder, Paul, Fauconnier, Jérémy, Boulkroun, Sheerazed, Ouvrard-Pascaud, Antoine

    Published in Archives of cardiovascular diseases (01-06-2024)
    “…Metabolic syndrome (MetS) and its related comorbidities significantly elevate the risk of heart failure with preserved ejection fraction (HFpEF), especially…”
    Get full text
    Journal Article